Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Silvia Pires Lourenco"'
Autor:
Silvia Pires Lourenco, Danuta Jarocha, Valentina Ghiaccio, Amaliris Guerra, Osheiza Abdulmalik, Ping La, Alexandra Zezulin, Kim Smith-Whitley, Janet L. Kwiatkowski, Virginia Guzikowski, Yukio Nakamura, Tobias Raabe, Laura Breda, Stefano Rivella
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/af3ad5908f5d468bbcfda257356590f8
Autor:
Danuta Jarocha, Janet L. Kwiatkowski, Tobias Raabe, Virginia Guzikowski, Silvia Pires Lourenco, Stefano Rivella, Yukio Nakamura, Amaliris Guerra, Kim Smith-Whitley, Alexandra Zezulin, Laura Breda, Ping La, Valentina Ghiaccio, Osheiza Abdulmalik
Publikováno v:
Haematologica. 106:2740-2745
Autor:
Silvia, Pires Lourenco, Danuta, Jarocha, Valentina, Ghiaccio, Amaliris, Guerra, Osheiza, Abdulmalik, Ping, La, Alexandra, Zezulin, Kim, Smith-Whitley, Janet L, Kwiatkowski, Virginia, Guzikowski, Yukio, Nakamura, Tobias, Raabe, Laura, Breda, Stefano, Rivella
Publikováno v:
Haematologica
Autor:
Naoto Tanaka, Silvia Pires Lourenco, Danuta Jarocha, Valentina Ghiaccio, Carla Casu, Kim Smith-Whitley, Virginia Guzikowski, Stefano Rivella, Laura Breda, Yasuhiro Ikawa, Janet L. Kwiatkowski
Publikováno v:
Blood. 134:2242-2242
The ongoing clinical trials, based on the use of lenti-globin vectors for beta-globinopathies, indicate that current vectors require high number of integrations (~3-4 copies per genome) in a pancellular fashion to make a patient transfusion independe
Publikováno v:
Blood. 132:851-851
Iron-sulfur (Fe-S) clusters are iron-containing prosthetic groups and enzymatic cofactors. They are strong oxidants when unbound yet essential in many processes like facilitating ATP production in mitochondria, promoting DNA, RNA and protein synthese
Autor:
Valentina Ghiaccio, Yukio Nakamura, Vanessa Carrion, Laura Breda, Ryo Kurita, Janet L. Kwiatkowski, Stefano Rivella, Carla Casu, Silvia Pires Lourenco, Virginia Guzikowski, Hanyia Zaidi, Kim Smith-Whitley
Publikováno v:
Blood. 132:3477-3477
Given that both Sickle Cell Disease (SCD) and beta-thalassemia (BT) are caused by mutations in the beta-globin gene, several lentivirus-based gene addition therapies have been developed. Results from recent trials indicate that the vectors used are s